A Dose-escalation Study to Investigate Safety and Toleration of OZ439
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
A randomised, placebo-controlled, dose-escalation study to investigate safety and toleration
of OZ439 OD for 3 days to healthy male and female volunteers. The study aims:
- To determine the safety and tolerability of ascending doses of OZ439 OD for three days.
- To assess pharmacokinetic parameters of ascending doses of OZ439 given OD.
- To identify the maximum tolerated dose of OZ439 administered.